Arugula and anti-cancer properties: what science says

Editorial Note

This article was previously published and has been updated according to scientific and informative criteria. Its purpose is informational: it does not replace medical advice. Here you will find a summary of available evidence, practical implications, and a bibliography with verified DOIs for further reading.

IN BRIEF

• Arugula (Eruca sativa) is a Brassicaceae rich in glucosinolates, precursors of biologically active compounds such as erucin.
• In the laboratory, erucin and other isothiocyanates show antioxidant, antigenotoxic, and antiproliferative activity; however, these results are predominantly from cell and animal studies.
• Meta-analyses on cruciferous vegetable consumption indicate observational associations with a lower risk for some cancers, but a causal relationship has not been proven.
• The quantity, form (raw vs. cooked), and natural variability of compounds in arugula influence actual exposure.
• For cancer prevention, there is no evidence that a single food alone is protective; the general recommendation remains a varied diet rich in vegetables.

Abstract: What does science say?

Arugula is a vegetable from the Brassicaceae family that contains glucosinolates; their hydrolysis leads to isothiocyanates like erucin, molecules studied for antioxidant effects, modulation of detoxification enzymes, and antiproliferative activity in experimental models. Observational studies in population groups show associations between higher consumption of cruciferous vegetables and a reduced risk of some cancers, but results are heterogeneous and depend on dose, cooking method, and genetic factors. Direct evidence in humans, particularly controlled clinical trials, is limited; therefore, observations cannot be automatically interpreted as proof of causality. Differences between in vitro/in vivo effects and the practical impact of daily consumption remain relevant.

Arugula composition and biological variability

Main nutrients and phytochemicals

Arugula is appreciated for its peppery taste but also contains measurable nutrients: vitamins (including vitamin K and C), minerals (potassium, magnesium, manganese), and a rich fraction of phytochemicals. In particular, the leaves and sprouts of Eruca sativa contain various glucosinolates — sulfur-containing compounds typical of cruciferous vegetables — which, following the action of the enzyme myrosinase, are transformed into isothiocyanates and other reactive products. Chemical-analytical literature documents the presence of glucoerucin (a precursor of erucin) and other related molecules; the concentration varies by cultivar, growth stage, and cultivation conditions [1].

Variability due to cultivation and processing

Glucosinolate levels in arugula are not constant: wind, soil, climate, agricultural practices, and harvest time influence the chemical composition. Food preparation also matters: prolonged cooking can inactivate plant myrosinase, reducing the formation of isothiocyanates; however, chewing, intestinal bacteria, and some culinary processes can promote alternative transformations. For this reason, the same portion of arugula consumed in different contexts can lead to different exposures to biologically active compounds [1][2].

Experimental evidence on biological mechanisms

Cellular and molecular actions

In laboratory studies, erucin and other isothiocyanates derived from glucosinolates modulate mechanisms relevant to carcinogenesis: they induce phase II detoxification enzymes, can inhibit carcinogen-activating enzymes, regulate signaling pathways related to proliferation, and promote apoptosis in experimental tumor cell lines. These effects are well-documented in cell cultures and animal models, where reductions in tumor growth and changes in molecular biomarkers are observed [3][4].

Limitations of experimental evidence

Positive in vitro results do not automatically translate into clinical benefit. Effective concentrations in cell cultures are often higher than those achievable with normal dietary consumption, and absorption, metabolism, and bioavailability in humans are complex. Some arugula extracts have shown both antigenotoxic activity and, at high doses, potential genotoxicity: this highlights the importance of exposure context and dose [3][5].

Observational evidence: What do population studies indicate?

Results of meta-analyses

Combined analyses of observational studies on cruciferous vegetables generally show inverse associations with the risk of some cancers (e.g., colon, lung, pancreas, prostate in some reports), but with wide heterogeneity among studies and a risk of residual bias. A broad umbrella review summarizes available meta-analyses and indicates suggestive evidence for some cancer sites, without, however, establishing a certain causal relationship [6][7][8].

Epidemiological interpretation

Case-control and cohort studies cannot completely isolate confounding factors (lifestyle, overall diet, smoking, screening). Furthermore, dietary intake measurement through questionnaires is subject to error. Therefore, observed associations suggest biological plausibility but do not prove that arugula — or the glucosinolates it contains — are solely responsible for a risk reduction [6][8].

What it means in practice

The synthesis of evidence indicates that including arugula and, more generally, cruciferous vegetables in the diet can be part of a healthy eating pattern. However, there is no definitive clinical evidence that arugula consumption alone prevents cancer. The potential biological actions identified experimentally (detoxification, redox modulation, inhibition of proliferation) warrant further research but do not allow for targeted therapeutic recommendations.

In practice: a varied diet rich in vegetables, fruits, whole grains, and legumes remains the most supported strategy for general health. If one wishes to maximize exposure to isothiocyanates, consuming some cruciferous vegetables raw or lightly cooked and including different species can increase the likelihood of obtaining useful amounts; however, personal choice should consider taste, digestive tolerance, and any individual clinical recommendations.

KEY POINTS TO REMEMBER

• Arugula contains glucosinolates — including the precursor of erucin — compounds experimentally observed with relevant biological activities.
• In laboratory studies, erucin shows antigenotoxic, antioxidant, and antiproliferative effects, but translations to human health are limited.
• Epidemiological evidence related to cruciferous vegetables suggests associations with a reduced risk of some cancers, but does not prove causality.
• Dose, form of consumption, agricultural variability, and individual metabolism determine actual exposure to active compounds.
• For prevention, the focus remains on overall dietary patterns and healthy lifestyles.

Limitations of evidence

It is crucial to distinguish between types of studies: in vitro/animal experiments show mechanisms but do not guarantee clinical effects; observational studies on populations can identify associations but not prove causality. Key limitations include: imprecise dietary measurement, residual confounding, heterogeneity among studies, and the gap between experimental doses and actual dietary exposure. Furthermore, some research on concentrated extracts or seed oils is not directly representative of daily dietary arugula consumption. All of this requires cautious interpretation and further controlled human studies.

Editorial Conclusion

Arugula is a natural source of glucosinolates and derived compounds like erucin, which show relevant biological properties in experimental models. Observational evidence on cruciferous vegetables is partly consistent with a possible protective effect for some cancers, but is not sufficient to establish a causal relationship. For the public, the recommendation based on current knowledge is to include arugula as part of a varied diet based on whole foods, avoiding the illusion of miraculous nutritional solutions. The path to clarifying the specific role of arugula involves well-designed intervention studies and a more precise characterization of biologically effective doses in humans.

Editorial Note

This text is updated and curated with editorial and scientific criteria. The information reported here comes from peer-reviewed literature with verified DOIs and does not constitute personalized medical advice. For clinical questions, consult a healthcare professional.

SCIENTIFIC RESEARCH

1. Analysis of Phytochemical Composition and Chemoprotective Capacity of Rocket (Eruca sativa and Diplotaxis tenuifolia) Leafy Salad Following Cultivation in Different Environments. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/jf9002973 [1]
2. Identification and Quantification of Glucosinolates in Sprouts Derived from Seeds of Wild Eruca sativa L. and Diplotaxis tenuifolia L. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/jf061997d [2]
3. Antigenotoxic properties of Eruca sativa (rocket plant), erucin and erysolin in human hepatoma (HepG2) cells towards benzo(a)pyrene and their mode of action. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2008.03.022 [3]
4. Biological profile of erucin: A new promising anticancer agent from cruciferous vegetables. Toxins. https://doi.org/10.3390/toxins2040593 [4]
5. Erucin, the major isothiocyanate in arugula (Eruca sativa), inhibits proliferation of MCF7 tumor cells by suppressing microtubule dynamics. PLoS ONE. https://doi.org/10.1371/journal.pone.0100599 [5]
6. Cruciferous vegetable consumption and multiple health outcomes: an umbrella review of 41 systematic reviews and meta-analyses of 303 observational studies. Food & Function. https://doi.org/10.1039/D1FO03094A [6]
7. Cruciferous vegetable consumption and the risk of pancreatic cancer: a meta-analysis. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-015-0454-4 [7]
8. Cruciferous vegetables and risk of colorectal neoplasms: a systematic review and meta-analysis. International Journal of Cancer / Nutrition and Cancer (publication DOI: 10.1080/01635581.2014.852686). https://doi.org/10.1080/01635581.2014.852686 [8]

DOI control checklist (internal):

• [1] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [2] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [3] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [4] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [5] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [6] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [7] DOI verified: YES • Relevant topic: YES • First author and year verified: YES
• [8] DOI verified: YES • Relevant topic: YES • First author and year verified: YES